First- and third-generation epidermal growth factor receptor inhibitors mediate distinct phosphoprotein signalling networks: implications for adverse dermatological reactions

Br J Dermatol. 2020 Dec;183(6):1105-1107. doi: 10.1111/bjd.19263. Epub 2020 Jul 27.

Authors

C Vasavda¹, B K Ho¹, D Y Zhang¹, K A Williams¹, B H Kaffenberger², S G Kwatra¹, M M Kwatra³

Affiliations

¹ Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
² Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
³ Department of Anesthesiology, Duke University School of Medicine, Durham, NC, 27701, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

ErbB Receptors
Humans
Phosphoproteins*
Protein Kinase Inhibitors*

Substances

Phosphoproteins
Protein Kinase Inhibitors
ErbB Receptors

Grants and funding